Menu
Other Vial/Ampoule

Lidocaine (Local Anesthetic)

Standard
Active Ingredient
-
Estimated Price
Not specified

Avoid systemic injection. Monitor heart rhythm.

Author Profile Picture
Medically Reviewed By
Prof. Dr. Mohamed Hutaif
Consultant Orthopedic Surgeon
Medical Disclaimer The information provided in this comprehensive guide is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with your physician before taking any new medication.

Comprehensive Clinical Guide: Lidocaine (Local Anesthetic)

Lidocaine, an amino-amide local anesthetic, stands as the gold standard in clinical practice for regional anesthesia and the management of ventricular arrhythmias. Since its synthesis in 1943, lidocaine has revolutionized minor surgical procedures, pain management, and emergency cardiac interventions. This guide serves as an authoritative resource for clinicians, anesthesiologists, and medical professionals regarding the pharmacology, clinical application, and safety protocols surrounding lidocaine.


1. Mechanism of Action: The Molecular Basis of Blockade

Lidocaine functions primarily by inhibiting the voltage-gated sodium channels (VGSCs) in the neuronal cell membrane.

The Sodium Channel Blockade

The anesthetic effect is achieved through a multi-step molecular process:
1. Diffusion: As a lipophilic molecule, lidocaine crosses the lipid bilayer of the nerve cell membrane.
2. Ionization: Once inside the axoplasm, the molecule encounters the acidic environment of the nerve and becomes protonated.
3. Binding: The ionized form binds to the intracellular portion of the voltage-gated sodium channel.
4. Inhibition: By stabilizing the inactivated state of the sodium channel, lidocaine prevents the influx of sodium ions required for the initiation and conduction of action potentials.

This blockade is frequency-dependent; nerves that are firing rapidly are more susceptible to the anesthetic effect. Furthermore, smaller, unmyelinated C-fibers (responsible for pain and temperature) are blocked before larger, myelinated A-fibers (responsible for motor function and proprioception).


2. Pharmacokinetics: Absorption, Distribution, Metabolism, and Excretion (ADME)

Understanding the pharmacokinetic profile is essential for preventing systemic toxicity.

Parameter Description
Onset of Action Rapid (typically 2–5 minutes)
Duration of Action 60–120 minutes (varies by site and concentration)
Protein Binding 60–80% (primarily to alpha-1-acid glycoprotein)
Metabolism Hepatic via cytochrome P450 (CYP1A2 and CYP3A4 enzymes)
Excretion Renal (less than 10% excreted unchanged)

Clinical Implications of ADME

  • First-Pass Effect: Lidocaine undergoes extensive first-pass metabolism in the liver; therefore, it is not administered orally for anesthetic purposes.
  • Tissue Blood Flow: The duration of action is highly dependent on vascularity. Injections in highly perfused areas (e.g., scalp) result in faster systemic absorption and shorter duration.
  • Active Metabolites: The primary metabolites, monoethylglycinexylidide (MEGX) and glycinexylidide (GX), possess pharmacological activity and can contribute to toxicity if accumulation occurs in patients with hepatic impairment.

3. Clinical Indications and Dosage Guidelines

Lidocaine is indicated for infiltration anesthesia, peripheral nerve blocks, epidural/spinal anesthesia, and the treatment of life-threatening ventricular arrhythmias.

Common Clinical Indications

  • Local Infiltration: Minor surgical procedures, suturing, and dermatological biopsies.
  • Nerve Blocks: Digital blocks, brachial plexus blocks, and dental anesthesia.
  • Topical Application: Mucous membrane anesthesia (e.g., oral/nasal sprays).
  • Cardiac: Management of acute ventricular tachycardia and ventricular fibrillation (ACLS protocols).

Dosage Considerations (Adults)

Note: Maximum doses vary based on patient weight and the presence of epinephrine.

Procedure Type Max Dose (Without Epinephrine) Max Dose (With Epinephrine)
Local Infiltration 4.5 mg/kg 7.0 mg/kg
Peripheral Nerve Block 4.5 mg/kg 7.0 mg/kg
Epidural Varies by space Varies by space

Critical Safety Rule: Never exceed the maximum milligram-per-kilogram limit. Epinephrine (1:200,000) is commonly added to constrict local vasculature, which reduces systemic absorption, prolongs the anesthetic effect, and increases the safety profile by allowing a higher total dose.


4. Contraindications and Drug Interactions

Contraindications

  • Hypersensitivity: History of allergic reaction to amide-type local anesthetics (rare, but documented).
  • Heart Block: Severe degrees of sinoatrial, atrioventricular, or intraventricular heart block (in the absence of an artificial pacemaker).
  • Severe Hepatic Impairment: Due to decreased metabolic clearance.
  • Infection: Do not inject into infected or inflamed tissue, as the acidic environment reduces the efficacy of the anesthetic.

Significant Drug Interactions

  • Antiarrhythmics: Increased risk of cardiac depression when combined with amiodarone, procainamide, or beta-blockers.
  • CYP450 Inhibitors: Drugs like cimetidine or propranolol can reduce lidocaine clearance, increasing the risk of systemic toxicity.
  • Vasoconstrictors: Use caution when combining epinephrine-laced lidocaine with MAO inhibitors or tricyclic antidepressants to avoid hypertensive crises.

5. Pregnancy, Lactation, and Pediatric Use

Pregnancy (FDA Category B)

Lidocaine crosses the placental barrier. It is generally considered safe for use during pregnancy, but clinicians should use the lowest effective dose. High doses during labor may lead to fetal bradycardia or neonatal depression.

Lactation

Lidocaine is excreted into breast milk in small quantities. It is generally considered compatible with breastfeeding, but monitoring the infant for signs of sedation or irritability is recommended.

Pediatric Considerations

Pediatric dosing must be calculated strictly based on lean body weight. The risk of systemic toxicity is higher due to immature hepatic enzyme systems.


6. Overdose Management: Local Anesthetic Systemic Toxicity (LAST)

LAST is a life-threatening emergency. Early recognition is paramount.

Signs of Toxicity

  1. CNS Excitation: Metallic taste, circumoral numbness, tinnitus, dizziness, restlessness, and muscle twitching.
  2. CNS Depression: Seizures, unconsciousness, and respiratory arrest.
  3. Cardiovascular: Myocardial depression, hypotension, bradycardia, and ventricular arrhythmias.

Management Protocol

  1. Stop Injection: Immediately cease the administration of lidocaine.
  2. Airway/Breathing: Maintain patent airway and administer 100% oxygen.
  3. Seizure Control: Benzodiazepines (e.g., midazolam) are the first-line treatment.
  4. Lipid Emulsion Therapy: For cardiovascular collapse, initiate 20% Intralipid infusion immediately.
  5. Advanced Cardiac Life Support: Follow standard ACLS algorithms, noting that lidocaine should not be used as an antiarrhythmic if the toxicity is due to lidocaine itself.

7. Frequently Asked Questions (FAQ)

1. What is the difference between Lidocaine and Procaine?

Lidocaine is an amide, whereas Procaine is an ester. Amides are metabolized in the liver, while esters are metabolized in the plasma by pseudocholinesterase. Lidocaine has a faster onset and longer duration.

2. Why does my patient feel a burning sensation upon injection?

The burning sensation is primarily due to the acidic pH of the lidocaine solution. Clinicians often add sodium bicarbonate (1 mEq per 10 mL of lidocaine) to buffer the solution and increase patient comfort.

3. Can I use lidocaine with epinephrine on fingers or toes?

Historically, this was discouraged due to fear of ischemic necrosis. However, current evidence suggests that in healthy patients, the use of 1:100,000 epinephrine in digital blocks is safe and provides better hemostasis.

4. How long does it take for lidocaine to wear off?

Typically, the numbing effect subsides within 1–2 hours, though this depends on the concentration used and the anatomical location of the block.

5. Is an allergy to lidocaine common?

True allergic reactions to amide anesthetics are extremely rare. Most "allergic" reactions reported by patients are actually vasovagal responses or reactions to the epinephrine/preservatives (e.g., methylparaben) in the solution.

6. What should I do if I accidentally inject into a vein?

Aspirate before every injection. If blood is aspirated, reposition the needle. If systemic toxicity symptoms occur, stop the procedure and follow the LAST management protocol.

7. Does lidocaine interact with common antibiotics?

There are no significant direct interactions between lidocaine and standard antibiotics, though caution is always advised when polypharmacy is involved.

8. Can lidocaine cause cardiac arrest?

Yes. In overdose situations, lidocaine can cause severe myocardial depression and refractory arrhythmias, which is why strict adherence to weight-based dosing is critical.

9. Why is lidocaine used in ACLS if it is a local anesthetic?

Lidocaine is a Class IB antiarrhythmic agent. It shortens the action potential duration and refractoriness in ischemic myocardial tissue, making it effective for suppressing ventricular ectopy.

10. How should lidocaine be stored?

Store at room temperature (20°C to 25°C). Avoid freezing and excessive heat. Inspect the vial for discoloration or particulate matter before use; if present, do not use.


Conclusion

Lidocaine remains an indispensable tool in the medical armamentarium. Its dual utility in pain management and cardiology necessitates a deep understanding of its pharmacological properties. By adhering to weight-based dosing, employing proper injection techniques, and maintaining vigilance for the signs of systemic toxicity, clinicians can ensure the safe and effective delivery of this potent anesthetic agent. Always consult your institution’s specific formulary and guidelines before administration.

Related Medical Information

Share this guide: